Adial Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
Adial Pharmaceuticals, Inc. (ADIL) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $77.86 thousand as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2023-03-30
- 2022-12-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $77.86K.
- 2022-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $77.86K.
- 2022-06-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $77.86K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2022-12-31 | $77.86K 10-K · filed 2023-03-30 |
| 2022-09-30 | $77.86K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $77.86K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |